Search research articles
Contact Us
Filters
Showing results (91-100 of 111) with videos related to
Page
of 12
Sort By:
Cancer Medicine
|
February 14, 2025
Survival Analysis of 4 Different Age Groups of Pancreatic Ductal Adenocarcinoma After Radical Resection From Retrospective Multi-Center Analysis (YPB-003)
Hiroto Matsui, Tatsuya Ioka, Toru Kawaoka, et al.
Annals of Gastroenterological Surgery
|
January 5, 2026
Outcomes of Resected Cases of Pancreatic Ductal Adenocarcinoma Patients With Unexpected Postoperative Uncovering Noncurative Factors: A Multicenter Retrospective Study
Hiroto Matsui, Naoki Ikenaga, Masafumi Nakamura, et al.
British Journal of Cancer
|
October 19, 2019
Correction: Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer
Taichi Kuwahara, Shoichi Hazama, Nobuaki Suzuki, et al.
British Journal of Cancer
|
September 7, 2019
Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer
Taichi Kuwahara, Shoichi Hazama, Nobuaki Suzuki, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 10, 2019
Identification of a Promiscuous Epitope Peptide Derived From HSP70
Hiroto Matsui, Shoichi Hazama, Koji Tamada, et al.
Oncology
|
October 16, 2022
CA19-9 in Combination with Methylated HOXA1 and SST Is Useful to Diagnose Stage I Pancreatic Cancer
Yutaka Suehiro, Shigeyuki Suenaga, Yuki Kunimune, et al.
Anticancer Research
|
December 30, 2022
Serum CCL7 Is a Novel Prognostic Biomarker of Metastatic Colorectal Cancer
Hikari Chidimatsu, Ryouichi Tsunedomi, Yuki Nakagami, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 17, 2023
Phase I study of a novel therapeutic vaccine as perioperative treatment for patients with surgically resectable hepatocellular carcinoma: The YCP02 trial
Masao Nakajima, Shoichi Hazama, Yukio Tokumitsu, et al.
In Vivo (Athens, Greece)
|
April 29, 2021
Rare Nivolumab-associated Super Hyper Progressive Disease in Patients With Advanced Gastric Cancer
Yutaro Kubota, Kiyoshi Yoshimura, Kazuyuki Hamada, et al.
BMC Cancer
|
October 17, 2022
CD4 and FOXP3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: applying a novel discrete Bayes decision rule
Yuki Nakagami, Shoichi Hazama, Nobuaki Suzuki, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 111) with videos related to
Sort By:
Page
of 12
Cancer Medicine
|
February 14, 2025
Survival Analysis of 4 Different Age Groups of Pancreatic Ductal Adenocarcinoma After Radical Resection From Retrospective Multi-Center Analysis (YPB-003)
Hiroto Matsui, Tatsuya Ioka, Toru Kawaoka, et al.
Annals of Gastroenterological Surgery
|
January 5, 2026
Outcomes of Resected Cases of Pancreatic Ductal Adenocarcinoma Patients With Unexpected Postoperative Uncovering Noncurative Factors: A Multicenter Retrospective Study
Hiroto Matsui, Naoki Ikenaga, Masafumi Nakamura, et al.
British Journal of Cancer
|
October 19, 2019
Correction: Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer
Taichi Kuwahara, Shoichi Hazama, Nobuaki Suzuki, et al.
British Journal of Cancer
|
September 7, 2019
Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer
Taichi Kuwahara, Shoichi Hazama, Nobuaki Suzuki, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 10, 2019
Identification of a Promiscuous Epitope Peptide Derived From HSP70
Hiroto Matsui, Shoichi Hazama, Koji Tamada, et al.
Oncology
|
October 16, 2022
CA19-9 in Combination with Methylated HOXA1 and SST Is Useful to Diagnose Stage I Pancreatic Cancer
Yutaka Suehiro, Shigeyuki Suenaga, Yuki Kunimune, et al.
Anticancer Research
|
December 30, 2022
Serum CCL7 Is a Novel Prognostic Biomarker of Metastatic Colorectal Cancer
Hikari Chidimatsu, Ryouichi Tsunedomi, Yuki Nakagami, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 17, 2023
Phase I study of a novel therapeutic vaccine as perioperative treatment for patients with surgically resectable hepatocellular carcinoma: The YCP02 trial
Masao Nakajima, Shoichi Hazama, Yukio Tokumitsu, et al.
In Vivo (Athens, Greece)
|
April 29, 2021
Rare Nivolumab-associated Super Hyper Progressive Disease in Patients With Advanced Gastric Cancer
Yutaro Kubota, Kiyoshi Yoshimura, Kazuyuki Hamada, et al.
BMC Cancer
|
October 17, 2022
CD4 and FOXP3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: applying a novel discrete Bayes decision rule
Yuki Nakagami, Shoichi Hazama, Nobuaki Suzuki, et al.
Page
of 12